1. Department of Biology, University of Pisa, Pisa, Italy;
2. Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany;
3. Hematology Department, Teaching Hospital No 1, Rzeszów, Poland;
4. Department of Hematology, Jagiellonian University Medical College, Cracow, Poland;
5. Lymphoma Department, Centre of Oncology-Institute of Maria Skłodowska-Curie, Warsaw, Poland;
6. Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany;
7. Max-Eder Research Group Experimental Therapies for Hematologic Malignancies, German Cancer Research Center (DKFZ), Heidelberg, Germany;
8. Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain;
9. Molecular Biology Laboratory, Section of Multiple Myeloma, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany;
10. Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland;
11. PTS Granada, Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, Granada, Spain;
12. Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves, Granada, Spain;
13. Pharmacogenetics Unit. Instituto de Investigación Biosanitaria de Granada (Ibs. Granada), Hospitales Universitarios de Granada / Universidad de Granada, Granada, Spain;
14. Department of Intrenal Medicine, Semmelweis University, Budapest, Hungary;
15. Department of Haematology, Copernicus Town Hospital of Torun, Torun, Poland;
16. Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal;
17. INSERM U900, Paris, France;
18. Institut Curie, Paris, France;
19. Mines ParisTech, Fontainebleau, France;
20. PSL University, Paris, France;
21. Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark;
22. National Research Centre for the Working Environment, Denmark;
23. Department of Hematology, University Hospital, Bydgoszcz, Poland;
24. Department of Haematology, Military Institute of Medicine, Warsaw, Poland;
25. Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy;
26. Department of Hematology, Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland;
27. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany;
28. Network Aging Research (NAR), University of Heidelberg, Heidelberg, Germany;
29. Cancer Research Center of Lyon, INSERM 1052/CNRS 5286, University of Lyon, Lyon, France;
30. Hospital 12 de Octubre, Complutense University, CNIO, CIBERONC, Madrid, Spain;
31. Department of Hematology, University Hospital of Salamanca, Salamanca, Spain;
32. National Center for Tumor Diseases (NCT), Heidelberg, Germany;
33. Division of Preventive Oncology, National Center for Tumor Diseases (NCT) German Cancer Research Center (DKFZ), Heidelberg, Germany;
34. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;
35. Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;
36. ICVS/3B’s – PT Government Associate Laboratory, Braga/Guimarães, Portugal;
37. Barretos Cancer Hospital, Molecular Oncology Research Center, S. Paulo, Brazil;
38. Department of Hematology, Holy Cross Oncology Center, Kielce, Poland;
39. Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;
40. Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland;
41. Department of Hematology, University Hospital Morales Meseguer, IMIB, Murcia, Spain;
42. Department of Clinical Immunology, Odense University Hospital, Odense, Denmark;
43. Department of Hematology, St. John’s Cancer Center, Lublin, Poland;
44. Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland;
45. Department of Hematology, Sea Hospital, Gdynia, Poland;
46. IRS-Center Sønderjylland, Aabenraa, Denmark;
47. Institute of Molecular Biology, University of Southern Denmark, Odense, Denmark;
48. Department of Haematology, University Hospital of Cracow, Cracow, Poland